Seizing the Moment: Why the Future of Manufacturing Belongs to Change Agents

For us, this step is more than a financial milestone. It’s about connecting our future with our roots — expanding our investor base and strengthening our ability to grow in sectors that matter, like healthcare, aerospace, and defense.

Our Nasdaq presence will remain a key pillar of our strategy. Adding Euronext Brussels reflects our confidence in the path ahead and our ambition to create meaningful impact for the benefit of industries, people, and society.

Since we announced our plans for the additional listing, I’ve often been asked, “Why now?”.

I believe it’s a fair question to ask.

After all, the additive manufacturing (AM) industry is going through a period of reflection. Many companies are struggling to turn innovation into profit. Investments have slowed. There’s growing skepticism about whether AM can truly deliver on its bold promise to transform manufacturing.

While it’s true that our industry is facing headwinds, and some choose to see obstacles, we choose to see opportunities. While others hesitate, we are ready to move!

The spirit of innovation and the passion to make a difference that guided our founders, Fried and Hilde, when they decided to make a giant leap 35 years ago, is the same spirit and passion that drives all of us at Materialise today. We are pioneers, and our products and technologies have defined our industry into what it is today.

In healthcare, for example, our innovations have helped shape the way personalized care is delivered. As we shift our focus from the technology itself to its application, our expertise in solving industry‑specific challenges increasingly positions us as not only an additive manufacturing leader, but also as a medical company, an aerospace company, and more.

At Materialise, we are a change agent, one whose ideas, technologies, and partnerships push industries toward new ways of thinking and working. We don’t look back at the change we’ve helped create — we look forward, determined to keep shaping what comes next.

When we examine the trends shaping our world and our industry, the message is clear: additive manufacturing is evolving from promise to purpose.

But it doesn’t end there. The challenge now is scaling that purpose across industries.

In healthcare, this means making personalized healthcare affordable, efficient, and available globally. It’s the essence of mass personalization — applying the innovation, creativity, and personalized technology used to transform one unique life, to improve millions more. Creating a world where the extraordinary becomes ordinary. Because the future of healthcare isn’t about care for the individual — it’s about individual care for all.

The same challenge — scaling our impact — also applies to the industrial markets we serve. Where our expertise and experience, our software and our services make a difference in the way products are designed, manufactured, and used — across industries, from aerospace and automotive to defense.

The challenge is great, but the task is clear:

1. Bring personalized care not to the individual, but to the masses
2. Transform highly-regulated industries through certified 3D‑printed parts and an integrated additive manufacturing software ecosystem

Ringing the bell at Euronext Brussels is not just a signal to the market — it’s a signal to our teams, our partners, our shareholders, our patients, and our customers. It says: Materialise is ready to accept the challenge and scale our impact. We are ready to transform what’s possible in healthcare, in aerospace, in every industry we touch. And it says that we will continue to innovate, not just because we can, but because we must — to improve lives, to create value, and to shape a better tomorrow.

That is what it means to be a change agent.